Page 1 of Clinical Trials for "9-hydroxy-risperidone", 130 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia
Last Updated: May 18, 2012
Condition(s): Schizophrenia
2
Terminated
A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls
Last Updated: April 14, 2011
Condition(s): Schizophrenia
3
Recruiting
Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients
Last Updated: May 9, 2012
Condition(s): Schizophrenia
4
Completed
Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia
Last Updated: June 8, 2011
Condition(s): Schizophrenia
5
Completed
Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
Last Updated: May 18, 2011
Condition(s): Schizoaffective Disorder; Psychotic Disorder
6
Not yet recruiting
Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia
Last Updated: October 11, 2011
Condition(s): Schizophrenia (Recent-onset)
7
Terminated
The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
Last Updated: May 1, 2012
Condition(s): Schizophrenia
8
Not yet recruiting
Study to Evaluate Effectiveness and Safety of Paliperidone Palmitate in Patients With Acute Schizophrenia
Last Updated: May 18, 2012
Condition(s): Schizophrenia
9
Completed
A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone
Last Updated: June 6, 2011
Condition(s): Schizophrenia
10
Completed
A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients
Last Updated: May 17, 2011
Condition(s): Schizophrenia
11
Completed
A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia
Last Updated: June 8, 2011
Condition(s): Schizophrenia
12
Withdrawn
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
Last Updated: March 24, 2011
Condition(s): Schizophrenia
13
Completed
A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate
Last Updated: April 26, 2010
Condition(s): Schizophrenia
14
Completed
A Study to Evaluate the Response to Treatment and Safety of Flexible Dose Treatment With Paliperidone ER in Patients With Schizophrenia
Last Updated: December 1, 2011
Condition(s): Schizophrenia
15
Completed
Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
Last Updated: May 18, 2011
Condition(s): Schizoaffective Disorder; Psychotic Disorder
16
Completed
Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease
Last Updated: May 18, 2011
Condition(s): Schizophrenia; Schizoaffective Disorder; Psychotic Disorders
17
Recruiting
Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning
Last Updated: October 27, 2010
Condition(s): Schizophrenia
18
Completed
Better Safety Profile of Paliperidone Extended-release Compared With Risperidone
Last Updated: February 9, 2012
Condition(s): Healthy Volunteer
19
Active, not recruiting
A Trial to Explore the Tolerability, Safety and Effectiveness of Paliperidone ER (Extended Release) Flexible Dosing in Patients With Schizophrenia
Last Updated: May 4, 2012
Condition(s): Schizophrenia
20
Recruiting
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
Last Updated: May 18, 2012
Condition(s): Schizophrenia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%229-hydroxy-risperidone%22

Page 1 of Clinical Trials for "9-hydroxy-risperidone", 130 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About